NTRS
49
-5
RF
51
-2
VRSN
53
-2
BBY
56
-2
TAP
45
-6
PCAR
50
-3
PDCO
54
-4
EXPD
53
-3
LNC
52
2
AN
50
-5
SCHW
52
3
MS
64
7
STT
51
-5
ISRG
68
-3
PNW
66
3
AMG
41
-3
C
60
-2
TDC
59
10
ADT
32
9
CMS
67
3
NTRS
49
-5
RF
51
-2
VRSN
53
-2
BBY
56
-2
TAP
45
-6
PCAR
50
-3
PDCO
54
-4
EXPD
53
-3
LNC
52
2
AN
50
-5
SCHW
52
3
MS
64
7
STT
51
-5
ISRG
68
-3
PNW
66
3
AMG
41
-3
C
60
-2
TDC
59
10
ADT
32
9
CMS
67
3
Financhill
Back

Vanguard Mid-Cap Growth ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
68

VOT
Vanguard Mid-Cap Growth ETF

Last Price:
240.80
Seasonality Move:
0.66%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
68
Vanguard Mid-Cap Growth ETF (VOT) is a Buy

Is Vanguard Mid-Cap Growth ETF a Buy, Sell or Hold?

  • The current Vanguard Mid-Cap Growth ETF [VOT] share price is $240.91. The Score for VOT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • VOT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

VOT Stock Price Chart

What is Vanguard Mid-Cap Growth ETF's stock price today?

  • The Vanguard Mid-Cap Growth ETF share price today is $240.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VOT is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

VOT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.95 Buy
Relative Strength Index (14 RSI): 64.46 Buy
Chaikin Money Flow: 107933 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (231.36 - 237.94) Buy
Bollinger Bands (100): (227.09 - 235.29) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

VOT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 236.81 Buy
20-day SMA: 234.69 Buy
50-day SMA: 232.06 Buy
200-day SMA: 227.09 Buy
8-day EMA: 237.27 Buy
20-day EMA: 234.86 Buy
50-day EMA: 232.75 Buy
200-day EMA: 225.24 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Vanguard Mid-Cap Growth ETF Earnings Growth & VOT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Vanguard Mid-Cap Growth ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):